Skip to search formSkip to main contentSkip to account menu

Abuse-Deterrent 24 HR Hydrocodone Bitartrate 80 MG Extended Release Oral Tablet [Hysingla]

Known as: HYDROCODONE BITARTRATE 80 mg ORAL TABLET, EXTENDED RELEASE [Hysingla ER], Hysingla ER 80 MG 24 HR Extended Release Oral Tablet, Hysingla ER 80 MG 24HR Extended Release Oral Tablet 
National Institutes of Health

Related topics

Related topics

14 relations
Butylated HydroxytolueneExtended Release Oral TabletHydrocodoneHydrocodone Bitartrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
(362) In vitro assessment of the effects of alcohol on the release rate of extended-release opioid formulations (Hysingla® ER, OxyContin® and Zohydro® ER).
2016
2016
(457) Effectiveness of Hysingla® ER, a once-daily, single-entity, hydrocodone with abuse-deterrent properties in treating chronic nonmalignant and nonneuropathic pain in patients with depression and…
2015
2015
12-Month safety and effectiveness of once-daily hydrocodone tablets formulated with abuse-deterrent properties in patients with moderate to severe chronic pain.
OBJECTIVE To characterize the long-term safety and effectiveness of Hysingla™ ER, single-entity, once-daily, extended-release… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)